Ron Levy
Scientific Advisory Board Member
Oncology
Innate pharma
France
Biography
Ron LEVY is a professor of medicine and Chief Division of Oncology at Stanford School of Medicine. His research is focused on the study of lymphomas and tumors of the immune system. He helped to develop and test the first antibody against cancer to be approved by the US Food and Drug Administration (FDA) for the treatment of lymphoma.
Research Interest
Oncology
